tiprankstipranks
Trending News
More News >
EuroEyes International Eye Clinic Limited (HK:1846)
:1846
Hong Kong Market

EuroEyes International Eye Clinic Limited (1846) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

EuroEyes International Eye Clinic Limited has a market cap or net worth of HK$872.98M. The enterprise value is HK$566.95M.
Market CapHK$872.98M
Enterprise ValueHK$566.95M

Share Statistics

EuroEyes International Eye Clinic Limited has 320,706,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding320,706,000
Owned by Insiders
Owned by Institutions

Financial Efficiency

EuroEyes International Eye Clinic Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.09%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)5.09%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee2.22M
Profits Per Employee392.75K
Employee Count322
Asset Turnover0.45
Inventory Turnover24.85

Valuation Ratios

The current PE Ratio of EuroEyes International Eye Clinic Limited is 15.85. EuroEyes International Eye Clinic Limited’s PEG ratio is -0.52.
PE Ratio15.85
PS Ratio0.00
PB Ratio0.86
Price to Fair Value1.19
Price to FCF16.02
Price to Operating Cash Flow9.16
PEG Ratio-0.52

Income Statement

In the last 12 months, EuroEyes International Eye Clinic Limited had revenue of 715.68M and earned 82.28M in profits. Earnings per share was 0.25.
Revenue715.68M
Gross Profit286.59M
Operating Income115.78M
Pretax Income126.47M
Net Income82.28M
EBITDA141.89M
Earnings Per Share (EPS)0.25

Cash Flow

In the last 12 months, operating cash flow was 103.00M and capital expenditures -46.77M, giving a free cash flow of 56.22M billion.
Operating Cash Flow103.00M
Free Cash Flow56.22M
Free Cash Flow per Share0.18

Dividends & Yields

EuroEyes International Eye Clinic Limited pays an annual dividend of HK$0.063, resulting in a dividend yield of 5.11%
Dividend Per ShareHK$0.063
Dividend Yield5.11%
Payout Ratio11.48%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.22
52-Week Price Change-47.40%
50-Day Moving Average2.90
200-Day Moving Average3.59
Relative Strength Index (RSI)33.66
Average Volume (3m)90.80K

Important Dates

EuroEyes International Eye Clinic Limited upcoming earnings date is Aug 27, 2025, TBA (Not Confirmed).
Last Earnings DateMar 31, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJun 10, 2025

Financial Position

EuroEyes International Eye Clinic Limited as a current ratio of 4.69, with Debt / Equity ratio of 29.21%
Current Ratio4.69
Quick Ratio4.58
Debt to Market Cap<0.01
Net Debt to EBITDA-2.35
Interest Coverage Ratio0.00

Taxes

In the past 12 months, EuroEyes International Eye Clinic Limited has paid 42.11M in taxes.
Income Tax42.11M
Effective Tax Rate0.33

Enterprise Valuation

EuroEyes International Eye Clinic Limited EV to EBITDA ratio is 6.84, with an EV/FCF ratio of 0.00.
EV to Sales1.36
EV to EBITDA6.84
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

EuroEyes International Eye Clinic Limited has HK$680.67M in cash and marketable securities with HK$319.29M in debt, giving a net cash position of -HK$361.38M billion.
Cash & Marketable SecuritiesHK$680.67M
Total DebtHK$319.29M
Net Cash-HK$361.38M
Net Cash Per Share-HK$1.13
Tangible Book Value Per ShareHK$2.55

Margins

Gross margin is 40.04%, with operating margin of 16.18%, and net profit margin of 11.50%.
Gross Margin40.04%
Operating Margin16.18%
Pretax Margin17.67%
Net Profit Margin11.50%
EBITDA Margin19.83%
EBIT Margin14.63%

Analyst Forecast

The average price target for EuroEyes International Eye Clinic Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast0.20%
EPS Growth Forecast-36.95%

Scores

Smart Score6
AI Score61
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis